phase 2_completion
saveEmory University — (carbidopa + levodopa) (Phase II Trial Completion)
community read0 votes
Therapy area: Central Nervous System. Indication: Cognitive Disorders, Depression
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- grantEMORY UNIVERSITY — Understanding Multidrug-Resistant Pathogen Infections and their Treatment wit...Apr 16, 2026
- grantEMORY UNIVERSITY — Changes in molecular mechanisms of dopamine signaling in advanced Parkinson's...Apr 15, 2026
- grantEMORY UNIVERSITY — Novel Long-Acting HBV Capsid Assembly ModulatorsApr 9, 2026
- grantEMORY UNIVERSITY — Targeting androgen-driven resistance to immune checkpoint inhibitors in pancr...Apr 6, 2026
- grantEMORY UNIVERSITY — The Role of Clonal Hematopoiesis in Lung Cancer: Immune Dysregulation and The...Apr 2, 2026
- grantEMORY UNIVERSITY — PREVENT study: Promoting resilience via early neurostimulation after traumaApr 1, 2026
related news · 8
- statHantavirus risk remains low, CDC says, citing its ‘playbook’ response
- oncliveGU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
- statThe aging scientific workforce collides with rising fabricating citations in medical journals
- statOpinion: We need more men in nursing
- oncliveASCO 2026 TNBC Deep Dive: Breast Cancer Experts Preview Practice-Informing Studies
- oncliveASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Go
- statSecuring NIH awards is getting more competitive — and confusing
- statNew U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project
🐶 often sniffed alongside
top 8- tagApproval8 co-mentions · 4 sources
- drugSINEMET CR5 co-mentions · 5 sources
- tagSmall Molecule4 co-mentions · 4 sources
- companyEmory University1 co-mentions · 1 sources
- tagMajor Depression1 co-mentions · 1 sources
- druglevodopa1 co-mentions · 1 sources
- drug(carbidopa + levodopa) CR1 co-mentions · 1 sources
- druglevodopa CR1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that